Weekly updateCompaniesRecruiting servicePost a job
Cogent Biosciences

Cogent Biosciences

    Company info:

  • 51-100
  • 2014
  • Cambridge, MA
  • 100-500M



Claim company profile

About company:

Cogent Biosciences is developing treatments for genetic diseases. Genetic mutations underpin and drive many diseases and require rational precision therapies to cure. Cogent is using established and emerging science to guide drug discovery and pioneer best-in-class therapeutics. Cogent’s most advanced program is Bezuclastinib, a potent and selective inhibitor of the protein Kit, a receptor tyrosine kinase. Kit is commonly mutated in gastrointestinal stromal tumors (GIST), and GIST patients often relapse with current therapeutics. Cogent hopes Bezuclastinib will offer a better clinical profile as it has already shown promising early clinical activity and safety. Cogent also has FGFR inhibitors in preclinical development for oncology.


Cogent Biosciences
Desktop Support (part time)
Cambridge, MA|19 days ago
Cogent Biosciences
Senior Clinical Trial Manager
Cambridge, MA|19 days ago
Cogent Biosciences
Senior Scientist, Medicinal Chemistry
Cambridge, MA|59 days ago
Cogent Biosciences
Director, Biostatistics
Cambridge, MA|68 days ago
Cogent Biosciences
Medical Writer
Cambridge, MA|100+ days ago

© 2022 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com